Amalgamated Bank’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-841
Closed -$28K 3015
2024
Q3
$28K Hold
841
﹤0.01% 2020
2024
Q2
$23K Hold
841
﹤0.01% 2071
2024
Q1
$18K Sell
841
-811
-49% -$17.7K ﹤0.01% 2184
2023
Q4
$10K Sell
1,652
-156
-9% -$777 ﹤0.01% 2867
2023
Q3
$10K Hold
1,808
﹤0.01% 2906
2023
Q2
$13K Buy
+1,808
New +$13.7K ﹤0.01% 2923

Amalgamated Bank's LBPH Position: Q4 2024 in Review

Amalgamated Bank sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 841 shares — an estimated $28K sold.

Amalgamated Bank first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $28K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Amalgamated Bank reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Amalgamated Bank sold 841 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $28K.
  • Amalgamated Bank first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
  • Amalgamated Bank's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $28K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Amalgamated Bank's 13F filing for Q4 2024, filed 4 Feb 2025.